Table 1.
Baseline characteristics.
| All (n = 116) |
Age ≥ 50 (n = 68) |
Age < 50 (n = 48) |
|
|---|---|---|---|
| Age y (mean [±SD]) | 50.3 (11.0) | 57.9 (5.0) | 39.6 (7.6) |
| Sex, male (%) | 9 (7.8%) | 5 (7.4%) | 4 (8.3%) |
| Serology tests, n (mean [±SD]) | 3.3 (1.7) | 3.3 (1.7) | 3.3 (1.7) |
| Days between vaccine doses (mean [±SD]) | 21.5 (1.0) | 21.3 (0.8) | 21.7 (1.1) |
3 individuals had not yet been eligible to receive the second dose of BNT162b2 by the time of data analysis. Two of these are older than 50.